» Articles » PMID: 23356220

Tight Junction-related Human Diseases

Overview
Journal Pathol Int
Specialty Pathology
Date 2013 Jan 30
PMID 23356220
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Tight junctions are intercellular junctions adjacent to the apical ends of paracellular spaces. They have two classical functions, the barrier function and the fence function. The former regulates the passage of ions, water and various molecules through paracellular spaces, and is thus related to edema, jaundice, diarrhea and blood-borne metastasis. The latter function maintains cell polarity by forming a fence to prevent intermixing of molecules in the apical membrane with those in the lateral membrane. This function is deeply involved in cancer cell properties in terms of loss of cell polarity. Recently, two novel aspects of tight junctions have been reported. One is their involvement in signal transduction. The other is that fact that tight junctions are considered to be a crucial component of innate immunity. In addition, since some proteins comprising tight junctions work as receptors for viruses and extracellular stimuli, pathogenic bacteria and viruses target and affect the tight junction functions, leading to diseases. In this review, the relationship between tight junctions and human diseases will be described.

Citing Articles

A Review of a Breakdown in the Barrier: Tight Junction Dysfunction in Dental Diseases.

Do T, Nguyen V, Nguyen N, Duong K, Nguyen T, Le D Clin Cosmet Investig Dent. 2025; 16:513-531.

PMID: 39758089 PMC: 11697688. DOI: 10.2147/CCIDE.S492107.


Anti-inflammatory activity of collagen peptide in vitro and its effect on improving ulcerative colitis.

Xin X, Zhou J, Liu G, Zhang M, Li X, Wang Y NPJ Sci Food. 2025; 9(1):1.

PMID: 39747094 PMC: 11697389. DOI: 10.1038/s41538-024-00367-7.


Effects of cold stress on the blood-brain barrier in Plectropomus leopardus.

Guo Y, Wei C, Ding H, Li P, Gao Y, Zhong K BMC Genomics. 2024; 25(1):1031.

PMID: 39497085 PMC: 11536950. DOI: 10.1186/s12864-024-10943-6.


Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trials.

Lordick F, Van Cutsem E, Shitara K, Xu R, Ajani J, Shah M ESMO Open. 2024; 9(8):103663.

PMID: 39146670 PMC: 11374961. DOI: 10.1016/j.esmoop.2024.103663.


Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

Shitara K, Xu R, Ajani J, Moran D, Guerrero A, Li R Gastric Cancer. 2024; 27(5):1058-1068.

PMID: 38954176 PMC: 11335819. DOI: 10.1007/s10120-024-01518-1.


References
1.
Honda H, Pazin M, Ji H, Wernyj R, Morin P . Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. J Biol Chem. 2006; 281(30):21433-21444. DOI: 10.1074/jbc.M603767200. View

2.
Igarashi Y, Utsumi H, Chiba H, Tobioka H, Kamimura Y, Furuuchi K . Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. Biochem Biophys Res Commun. 1999; 261(1):108-12. DOI: 10.1006/bbrc.1999.0992. View

3.
Kominsky S, Argani P, Korz D, Evron E, Raman V, Garrett E . Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 2003; 22(13):2021-33. DOI: 10.1038/sj.onc.1206199. View

4.
Leotlela P, Wade M, Duray P, Rhode M, Brown H, Rosenthal D . Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene. 2006; 26(26):3846-56. DOI: 10.1038/sj.onc.1210155. View

5.
Michl P, Buchholz M, Rolke M, Kunsch S, Lohr M, McClane B . Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology. 2001; 121(3):678-84. DOI: 10.1053/gast.2001.27124. View